Stocktoria

CollPlant Biotechnologies Ltd CLGN

CollPlant Biotechnologies Ltd statistics & valuation

P / S2.0×
P / B0.8×
Net margin-484.6%
FCF margin-398.4%
Return on capital-141.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-481.60% -94.10% 1.50% -5660.50% -64.00% -3225.00% -484.60% 2019202020212022202320242025
Gross margin (%)
18.90% 51.10% 87.20% -33.80% 81.80% -215.50% 64.80% 2019202020212022202320242025
Operating margin (%)
-329.20% -91.20% 0.40% -5718.10% -68.50% -3349.70% -484.30% 2019202020212022202320242025
Return on equity (%)
-273.10% -129.00% 0.50% -52.40% -24.80% -123.30% -188.90% 2019202020212022202320242025
Shares outstanding
5.7M 7.0M 12.0M 11.2M 11.5M 11.5M 12.8M 2019202020212022202320242025
Net debt ($)
-$3.7M -$3.3M -$13.1M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-103.80% -53.30% 0.50% -44.80% -20.60% -88.80% -106.50% 2019202020212022202320242025
Free cash flow margin (%)
-310.40% -79.60% 6.90% -5007.40% -33.90% -2830.30% -398.40% 2019202020212022202320242025
Debt / equity (×)
0.02× 0.00× 0.00× 2019202020212022202320242025
EPS ($)
-$2.23 -$0.84 $0.02 -$1.53 -$0.62 -$1.45 -$0.94 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin64.8%-215.5%81.8%-33.8%87.2%51.1%18.9%
Operating margin-484.3%-3349.7%-68.5%-5718.1%0.4%-91.2%-329.2%
Net margin-484.6%-3225.0%-64.0%-5660.5%1.5%-94.1%-481.6%
FCF margin-398.4%-2830.3%-33.9%-5007.4%6.9%-79.6%-310.4%
Return on assets-106.5%-88.8%-20.6%-44.8%0.5%-53.3%-103.8%
Return on equity-188.9%-123.3%-24.8%-52.4%0.5%-129.0%-273.1%
Debt / equity0.00×0.00×0.02×
Current ratio2.534.448.6210.2014.961.681.46

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.